In the Media

September 21, 2021

Is the industry ready for synthesized cannabinoids?

InMed CEO, Eric A. Adams, speaks with Shadd Dales of The Dales Report, and talks about whether the industry is ready for synthesized cannabinoids.

Read the article and watch the full video at The Dales Report.

Source: The Dales Report

Share this post

Latest Articles

Conference Presentation – InMed Presents at Life Sciences Forum December 11, 2025

In this update on InMed Pharmaceuticals, CEO Eric A. Adams talks about the company’s Alzheimer’s disease program. Mr. Adams talks about the role of inflammation

January 12, 2026

Fierce Biotech Article: Neuroinflammation a Key Underlying Factor in Alzheimer’s Disease Risk

Article featured in Fierce Biotech October 16, 2025 Excerpt: New findings discussed at the latest Alzheimer’s Association International Conference (AAIC) highlight the risk factors associated

October 27, 2025

InMed Presents at the 2025 Life Sciences Investor Forum

Video Replay Now Available: InMed’s CEO, Eric A. Adams, presents at the 2025 Life Sciences Investor Forum. In the presentation, which was originally published on

October 14, 2025